Aurgalys Team
Selected Customers
Interim Management
Quantum Genomics [ALQGC]
Corporate Finance
Management Assistance
Due Diligence
Interim Management
Investor Assistance
Onxeo [ONXEO]
Diaxonhit [ALEHT]

.:: Implanet [ALIMP] ::.

Implanet is a French company specializing in the design, development and commercialization of implantable medical devices for orthopedic surgery. In this high-tech therapeutic area, the company offers a comprehensive range of innovative implants for spine and knee surgery, including the JAZZ  implants.

The coverage was initiated July 12th, 2016

Our target price for Implanet as of April 25th, 2018,  is €1.40/ share.

From Oct 30th, 2017, Aurgalys analyst reports on Implanet will be published in English and French

A partir du 30 octobre 2017, les rapports d’analyse d’Aurgalys sur Implanet seront publiés en Français et en Anglais